Microneedles as Gateways: Smart Nanoparticle Delivery for Enhanced Breast Cancer Treatment

Area of Science:

• Oncology
• Biotechnology
• Materials Science

Background:

• Breast cancer necessitates advanced therapeutic strategies due to treatment challenges like side effects and multidrug resistance.
• Current treatments (surgery, chemotherapy, radiation) show limitations in efficacy and patient quality of life.
• Nanomedicine offers targeted drug delivery using nanoparticles (NPs) to improve biocompatibility and reduce toxicity.

Purpose of the Study:

• To explore the synergistic potential of nanoparticles and microneedle (MN) technology for advanced breast cancer therapy.
• To review the design, fabrication, and application of MNs for localized drug delivery.
• To address challenges and future perspectives in translating these nanomedicine approaches to clinical practice.

Main Methods:

• Review of current literature on nanoparticle-based breast cancer treatments.
• Analysis of microneedle technology for transdermal drug delivery.
• Investigation of integrated nanoparticle-microneedle systems for controlled drug release.
• Examination of clinical translation barriers and regulatory considerations.

Main Results:

• Nanoparticles enhance drug delivery, improving biocompatibility and reducing systemic toxicity in breast cancer treatment.
• Microneedles provide a minimally invasive platform for localized drug delivery, increasing bioavailability at tumor sites.
• Integrated NP-MN systems promise precise, controlled drug release, potentially overcoming limitations of individual approaches.

Conclusions:

• The combination of nanoparticles and microneedles presents a promising strategy for optimizing breast cancer therapy.
• Further research and development are crucial to overcome challenges in clinical translation and regulatory approval.
• This integrated approach holds potential for improved patient outcomes and quality of life in breast cancer management.